We are live on ! Find out more
SCM

Sterling Capital Management Portfolio holdings

AUM $5.9B
1-Year Est. Return 29.63%
This Fund
S&P 500
This Quarter Est. Return
+1.97%
1 Year Est. Return
+29.63%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.3B
AUM Growth
-$438M
Cap. Flow
-$385M
Cap. Flow %
-5.28%
Top 10 Hldgs %
23.31%
Holding
3,320
New
46
Increased
2,165
Reduced
525
Closed
74

Top Buys

Rank Stock Value
1
EG icon
Everest Group
EG
+$103M
2
CTRA
Coterra Energy
CTRA
+$89.5M
3
CVX icon
Chevron
CVX
+$55.9M
4
BDX icon
Becton Dickinson
BDX
+$55.8M
5
ROK icon
Rockwell Automation
ROK
+$51M

Top Sells

Rank Stock Value
1
NDAQ icon
Nasdaq
NDAQ
+$90.2M
2
AFL icon
Aflac
AFL
+$85.3M
3
HSY icon
Hershey
HSY
+$53.5M
4
JNJ icon
Johnson & Johnson
JNJ
+$48.8M
5
ABBV icon
AbbVie
ABBV
+$46.6M

Sector Composition

Rank Sector Weight
1 Technology 23.63%
2 Financials 18.4%
3 Healthcare 12.02%
4 Consumer Discretionary 8.91%
5 Industrials 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HLIT icon
2776
Harmonic Inc
HLIT
$1.26B
$1.5K ﹤0.01%
113
– –
CTLP
2777
DELISTED
Cantaloupe
CTLP
$1.49K ﹤0.01%
157
+90
+134% +$819
PHR icon
2778
Phreesia
PHR
$769M
$1.48K ﹤0.01%
59
+1
+2% +$21
PRPL icon
2779
Purple Innovation
PRPL
$39.6M
$1.48K ﹤0.01%
76
+69
+986% +$1.56K
WT icon
2780
WisdomTree
WT
$3.36B
$1.48K ﹤0.01%
141
– –
COCO icon
2781
Vita Coco
COCO
$3.63B
$1.48K ﹤0.01%
40
– –
ATEX icon
2782
Anterix
ATEX
$1.81B
$1.47K ﹤0.01%
48
+33
+220% +$1.1K
ABUS icon
2783
Arbutus Biopharma
ABUS
$907M
$1.47K ﹤0.01%
449
+288
+179% +$1.06K
ZUO
2784
DELISTED
Zuora, Inc.
ZUO
$1.47K ﹤0.01%
148
+2
+1% +$19
URG
2785
Ur-Energy
URG
$564M
$1.47K ﹤0.01%
1,276
+943
+283% +$1.16K
USLM icon
2786
United States Lime & Minerals
USLM
$3.45B
$1.46K ﹤0.01%
11
+1
+10% +$127
TCRX icon
2787
TScan Therapeutics
TCRX
$50.1M
$1.46K ﹤0.01%
480
+412
+606% +$1.87K
CBUS icon
2788
Cibus
CBUS
$146M
$1.43K ﹤0.01%
516
+469
+998% +$1.82K
PROK icon
2789
ProKidney
PROK
$347M
$1.43K ﹤0.01%
843
+749
+797% +$1.35K
IMVT icon
2790
Immunovant
IMVT
$8.24B
$1.41K ﹤0.01%
57
-1
-2% -$28
SKYE icon
2791
Skye Bioscience
SKYE
$18.7M
$1.39K ﹤0.01%
492
+442
+884% +$1.85K
ASTH icon
2792
Astrana Health
ASTH
$1.86B
$1.39K ﹤0.01%
44
– –
APPN icon
2793
Appian
APPN
$2.55B
$1.39K ﹤0.01%
42
– –
PRAX icon
2794
Praxis Precision Medicines
PRAX
$10.2B
$1.39K ﹤0.01%
18
– –
PGNY icon
2795
Progyny
PGNY
$2.18B
$1.36K ﹤0.01%
79
-63,417
-100% -$984K
OCUL icon
2796
Ocular Therapeutix
OCUL
$2.03B
$1.35K ﹤0.01%
158
– –
WRLD icon
2797
World Acceptance Corp
WRLD
$871M
$1.35K ﹤0.01%
12
+8
+200% +$934
CSTM icon
2798
Constellium
CSTM
$3.98B
$1.34K ﹤0.01%
131
-15,010
-99% -$185K
ATEN icon
2799
A10 Networks
ATEN
$2.06B
$1.34K ﹤0.01%
73
– –
SQQQ icon
2800
ProShares UltraPro Short QQQ
SQQQ
$1.75B
$1.34K ﹤0.01%
9
– –
110 111
112
113 114

Similar funds

WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
CIC
Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return
BSL
Blue Sparrow LLC Dover, Delaware $5.85B AUM
MWM
Modern Wealth Management Lenexa, Kansas $5.84B AUM 16.73% 1-Year Est. Return

Sterling Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Sterling Capital Management held 3,320 positions worth $7.3B, down 5.7% from $7.74B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Sterling Capital Management withdrew a net $385M in Q4 2024, closing 74 positions and reducing 525 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $4.12M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Sterling Capital Management opened a new position in iShares Russell 1000 Value ETF worth $10.5M.

  • Sterling Capital Management's largest Q4 2024 buy was iShares Russell 1000 Value ETF: 56,923 shares worth $10.5M.
  • Sterling Capital Management added most to Everest Group in Q4 2024, an estimated $103M increase.
  • Sterling Capital Management's biggest Q4 2024 reduction was Nasdaq, cutting an estimated $90.2M.
  • Sterling Capital Management fully exited iShares Russell 1000 Growth ETF in Q4 2024, selling an estimated $4.12M.
  • Sterling Capital Management's ten largest holdings make up 23% of its $7.3B portfolio in Q4 2024.
  • Sterling Capital Management opened 46 new positions and closed 74 in Q4 2024.
  • Sterling Capital Management's portfolio value fell 5.7% quarter-over-quarter to $7.3B.

Based on Sterling Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.